Dopamine release from transplanted neural stem cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 44, 2014, Pages 15804-15809

  Liu, Bin ^a   Kang, Xinjiang ^a   Xu, Huadong ^a   Teng, Sasa ^a   Zhang, Xiaoyu ^a   Deng, Zijun ^a   Zhou, Li ^a   Zuo, Panli ^a   Liu, Bing ^a   Wu, Qihui ^a   Wang, Li ^a   Hu, Meiqin ^a   Dou, Haiqiang ^a   Liu, Wei ^a   Zhu, Feipeng ^a   Li, Qing ^a   Guo, Shu ^a   Gu, Jingli ^a   Lei, Qian ^a   Lü, Jing ^a   Mu, Yu ^a   Jin, Mu ^a   Wang, Shirong ^a   Jiang, Wei ^b   Liu, Kun ^c   Wang, Changhe ^a   Li, Wenlin ^d   Zhang, Kang ^b,e,f   Zhou, Zhuan ^a   more..

^a Peking University   (China)

^b SICHUAN UNIVERSITY   (China)

^c CAPITAL UNIVERSITY OF PHYSICAL EDUCATION AND SPORTS   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

CFE; Dopamine; Neural stem cells; Parkinsons disease; Striatum in vivo

Indexed keywords

CARBON FIBER; DOPAMINE; TYROSINE 3 MONOOXYGENASE;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DEPOLARIZATION; DOPAMINE RELEASE; ELECTROCHEMISTRY; ELECTRODE; EMBRYONIC STEM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICRODIALYSIS; NERVE CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; ROTATION; ANIMAL; CELL DIFFERENTIATION; DOPAMINERGIC NERVE CELL; MALE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; STEM CELL TRANSPLANTATION; TRANSPLANTATION; XENOGRAFT;

RATTUS;

ANIMALS; CELL DIFFERENTIATION; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; HETEROGRAFTS; HUMANS; MALE; NEURAL STEM CELLS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TYROSINE 3-MONOOXYGENASE;

EID: 84914674246     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1408484111     Document Type: Article

References (50)

1. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123-144.
2. Barker RA, Barrett J, Mason SL, Björklund A (2013) Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease. Lancet Neurol 12(1):84-91.
3. Lindvall O, et al. (1990) Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247(4942):574-577.
4. Piccini P, et al. (1999) Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2(12):1137-1140.
5. Freed CR, et al. (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327(22):1549-1555.
6. Kordower JH, et al. (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332(17):1118-1124.
7. Widner H, et al. (1992) Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 327(22):1556-1563.
8. Bjorklund LM, et al. (2002) Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99(4): 2344-2349.
9. Hargus G, et al. (2010) Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 107(36):15921-15926.
10. Kim J, et al. (2011) Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell 9(5):413-419.
11. Kim JH, et al. (2002) Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418(6893):50-56.
12. Kriks S, et al. (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480(7378):547-551.
13. Roy NS, et al. (2006) Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12(11):1259-1268.
14. Studer L, Tabar V, McKay RD (1998) Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1(4):290-295.
15. Yang D, Zhang ZJ, Oldenburg M, Ayala M, Zhang SC (2008) Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 26(1):55-63.
16. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD (2000) Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18(6):675-679.
17. Perrier AL, et al. (2004) Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 101(34):12543-12548.
18. Li W, et al. (2011) Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc Natl Acad Sci USA 108(20):8299-8304.
19. Kirkeby A, et al. (2012) Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Reports 1(6):703-714.
20. Cho MS, et al. (2008) Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 105(9): 3392-3397.
21. Kawasaki H, et al. (2000) Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28(1):31-40.
22. Takagi Y, et al. (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115(1):102-109.
23. Zeng X, et al. (2004) Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22(6):925-940.
24. Gobert A, Billiras R, Cistarelli L, Millan MJ (2004) Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: Release from adrenergic terminals and modulation by alpha2-autoreceptors. J Neurosci Methods 140(1-2):141-152.
25. Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10(3):211-223.
26. Hoffman AF, Lupica CR, Gerhardt GA (1998) Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices. J Pharmacol Exp Ther 287(2):487-496.
27. Gerhardt GA, Oke AF, Nagy G, Moghaddam B, Adams RN (1984) Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res 290(2):390-395.
28. Kehr J (1999) Monitoring Chemistry of Brain Microenvironment: Biosensors, Microdialysis and Related Techniques. Modern Techniques in Neuroscience Research, eds Windhorst U, Johansson H (Springer, Berlin), pp 1149-1198.
29. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY (2002) Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 20(11):1103-1110.
30. Redmond DE, Jr, et al. (2007) Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 104(29):12175-12180.
31. Bouchez G, et al. (2008) Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem Int 52(7): 1332-1342.
32. Liu K, Steketee JD (2011) Repeated exposure to cocaine alters medial prefrontal cortex dopamine D2-like receptor modulation of glutamate and dopamine neurotransmission within the mesocorticolimbic system. J Neurochem 119(2):332-341.
33. Rodríguez-Gómez JA, et al. (2007) Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25(4): 918-928.
34. Wang SR, et al. (2011) Role of vesicle pools in action potential pattern-dependent dopamine overflow in rat striatum in vivo. J Neurochem 119(2):342-353.
35. Wightman RM (2006) Detection technologies. Probing cellular chemistry in biological systems with microelectrodes. Science 311(5767):1570-1574.
36. Anzalone A, et al. (2012) Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci 32(26):9023-9034.
37. Huang HP, et al. (2007) Long latency of evoked quantal transmitter release from somata of locus coeruleus neurons in rat pontine slices. Proc Natl Acad Sci USA 104(4): 1401-1406.
38. Wightman RM, et al. (1991) Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells. Proc Natl Acad Sci USA 88(23): 10754-10758.
39. Chen XK, et al. (2005) Activation of GPCRs modulates quantal size in chromaffin cells through G(betagamma) and PKC. Nat Neurosci 8(9):1160-1168.
40. Zhou Z, Misler S (1995) Action potential-induced quantal secretion of catecholamines from rat adrenal chromaffin cells. J Biol Chem 270(8):3498-3505.
41. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson' s disease. Nat Med 14(5):504-506.
42. Lindvall O, Kokaia Z, Martinez-Serrano A (2004) Stem cell therapy for human neurodegenerative disorders-How to make it work. Nat Med 10(Suppl):S42-S50.
43. Dunnett SB, Björklund A, Lindvall O (2001) Cell therapy in Parkinson' s disease-Stop or go? Nat Rev Neurosci 2(5):365-369.
44. Chung S, et al. (2011) ES cell-derived renewable and functional midbrain dopaminergic progenitors. Proc Natl Acad Sci USA 108(23):9703-9708.
45. Ganat YM, et al. (2012) Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J Clin Invest 122(8):2928-2939.
46. Mundorf ML, Joseph JD, Austin CM, Caron MG, Wightman RM (2001) Catecholamine release and uptake in the mouse prefrontal cortex. J Neurochem 79(1):130-142.
47. Schmitz Y, Schmauss C, Sulzer D (2002) Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci 22(18):8002-8009.
48. Wu Q, et al. (2002) Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: An in vivo voltammetric study. J Neurosci 22(14):6272-6281.
49. Wang L, et al. (2014) Modulation of dopamine release in the striatum by physiologically relevant levels of nicotine. Nat Commun 5:3925.
50. Liu T, et al. (2011) Calcium triggers exocytosis from two types of organelles in a single astrocyte. J Neurosci 31(29):10593-10601.